ArticleScientific reports2025
Prediction of axillary lymph node metastasis in triple negative breast cancer using MRI radiomics and clinical features.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Dynamic nomogram for predicting axillary lymph node metastasis in breast cancer based on MRI analysis and the platelet-to-lymphocyte ratio (PLR).Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
- Artificial intelligence for triple-negative breast cancer from imaging to multi-omics.Frontiers in oncology · 2026Review
- Multicenter Validation of an Integrated DCE-MRI Radiomics, Deep Learning, and S-II Model for Predicting Axillary Lymph Node Metastasis in Breast Cancer.Journal of multidisciplinary healthcare · 2026Article
- Multi-parametric MRI habitat radiomics with interpretable machine learning for early prediction of axillary lymph node metastasis in triple-negative breast cancer.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
To develop and validate a machine learning-based prediction model to predict axillary lymph node (ALN) metastasis in triple negative breast cancer (TNBC) patients using magnetic resonance imaging (MRI) and clinical characteristics. This retrospective study included TNBC patients from the First Affiliated Hospital of Soochow University and Jiangsu Province Hospital (2016-2023). We analyzed clinical characteristics and radiomic features from T2-weighted MRI. Using LASSO regression for feature selection, we applied Logistic Regression (LR), Random Forest (RF), and Support Vector Machine (SVM) to build prediction models. A total of 163 patients, with a median age of 53 years (range: 24-73), were divided into a training group (n = 115) and a validation group (n = 48). Among them, 54 (33.13%) had ALN metastasis, and 109 (66.87%) were non-metastasis. Nottingham grade (P = 0.005), tumor size (P = 0.016) were significant difference between non-metastasis cases and metastasis cases. In the validation set, the LR-based combined model achieved the highest AUC (0.828, 95%CI: 0.706-0.950) with excellent sensitivity (0.813) and accuracy (0.812). Although the RF-based model had the highest AUC in the training set and the highest specificity (0.906) in the validation set, its performance was less consistent compared to the LR model. MRI-T2WI radiomic features predict ALN metastasis in TNBC, with integration into clinical models enhancing preoperative predictions and personalizing management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.